EWING SARCOMA METASTATIC

Clinical trials for EWING SARCOMA METASTATIC explained in plain language.

Never miss a new study

Get alerted when new EWING SARCOMA METASTATIC trials appear

Sign up with your email to follow new studies for EWING SARCOMA METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for young bone cancer patients: can an added drug keep cancer away?

Disease control Not yet recruiting

This study is testing if adding a drug called eflornithine (DFMO) to standard chemotherapy can help young people with Ewing sarcoma or osteosarcoma. It aims to see if this combination helps patients live longer without their cancer coming back. The trial will enroll about 406 par…

Matched conditions: EWING SARCOMA METASTATIC

Phase: PHASE2 • Sponsor: Milton S. Hershey Medical Center • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

EWING SARCOMA METASTATIC

Get alerted when new EWING SARCOMA METASTATIC trials appear

New hope for young bone cancer patients: can an added drug keep cancer away?